Biopharmaceutical profile of cerivastatin, a novel HMG-CoA reductase inhibitor

被引：5
|
作者：
Muck, W
Ochmann, K
Mazzu, A
Lettieri, J
机构：
[1] BAYER AG,CLIN PHARMACOL,D-5600 WUPPERTAL,GERMANY
[2] BAYER CORP,CLIN PHARMACOL,W HAVEN,CT
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88701-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [31] Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia
    Tazuma, S
    Yamashita, G
    Ochi, H
    Miura, H
    Kajihara, T
    Hattori, Y
    Miyake, H
    Nishioka, T
    Hyogo, H
    Sunami, Y
    Yasumiba, S
    Kajiyama, G
    CLINICAL THERAPEUTICS, 1998, 20 (03) : 477 - 485
  • [32] Novel role of HMG-CoA reductase inhibitor in keratinocyte proliferation and migration
    Attja, M. I.
    Murota, H.
    Katayama, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S57 - S57
  • [33] Rhabdomyolysis following cerivastatin monotherapy - implications for therapy with HMG-CoA reductase inhibitors
    Sparing, R
    Sellhaus, B
    Noth, J
    Block, F
    NERVENARZT, 2003, 74 (02): : 167 - +
  • [34] Photoaffinity labeling of HMG-CoA reductase with azido-functionalized cerivastatin derivatives
    Ikemoto, T
    Hosoya, T
    Hiramatsu, T
    Nakanishi, M
    Hosoya, A
    Aoyama, H
    Iwata, T
    Maruyama, K
    Suzuki, M
    Endo, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 139P - 139P
  • [35] Cataract and HMG-CoA reductase inhibitor: a case report
    Bousquet, E
    Amar, J
    Salvador, M
    Chamontin, B
    THERAPIE, 1998, 53 (05): : 505 - 507
  • [36] EFFICACY OF THE SYNTHETIC HMG-COA REDUCTASE INHIBITOR FLUVASTATIN
    KEILSON, L
    DUJOVNE, C
    HUNNINGHAKE, D
    INSULL, W
    KNOPP, R
    MCKENNEY, J
    STEIN, E
    TROENDLE, A
    ARTERIOSCLEROSIS, 1990, 10 (05): : A856 - A856
  • [37] THE PHARMACOLOGY OF FLUVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR
    GARNETT, WR
    CLINICAL CARDIOLOGY, 1994, 17 (12) : 3 - 10
  • [38] HMG-COA REDUCTASE INHIBITOR THERAPY AND PERIPHERAL NEUROPATHY
    JACOBS, MB
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) : 970 - 970
  • [39] Lovastatin -: Mevacor® -: Hypolipidemic -: HMG-CoA reductase inhibitor
    不详
    DRUGS OF THE FUTURE, 2001, 26 (03) : 302 - 303
  • [40] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Valeriy V. Pak
    Dae Yong Kwon
    Olim K. Khojimatov
    Aleksandr V. Pak
    Shomansur Sh. Sagdullaev
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 1923 - 1931
12345